Evaluating the Genomic Composition of AAV Vectors & It’s Impact on Gene Therapies
Time: 2:45 pm
day: Day One
This presentation aims to answer key questions such as:
- What are the key DNA configurations of AAV vectors?
- What are the biological effects of AAV contaminants?
- How to make vectors free of such contaminants?